封面
市场调查报告书
商品编码
1741298

苯丁酸钠市场按应用、分销管道、最终用户和地区划分

Sodium Phenylbutyrate Market, By Application, By Distribution Channel, By End-User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年苯丁酸钠市场规模为 21.9 亿美元,到 2032 年将达到 34.5 亿美元,2025 年至 2032 年的复合年增长率为 6.7%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 21.9亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 6.70% 2032年价值预测 34.5亿美元

苯丁酸钠 (SPB) 是一种卓越的药物化合物,在医学研究和治疗方法中备受关注。作为苯丁酸的衍生物,SPB 表现出广泛的治疗特性,使其成为治疗多种疾病的有希望的候选药物。 SPB 的主要应用是治疗尿素循环障碍,这是一种遗传性疾病,患者体内有效排放氨的能力受到损害。此外,目前正在进行的研究正在探索其在缓解神经退化性疾病和癌症方面的潜力。本文旨在阐明苯丁酸钠在推动医学进步和改善患者照护扮演的重要角色。

市场动态:

尿素循环障碍 (UCD) 盛行率的上升、罕见疾病意识的增强和诊断水平的提高以及孤儿药开发的不断扩大,预计将在预测期内推动全球苯丁酸钠市场的成长。此外,药物研发的进步也有望在预测期内推动全球苯丁酸钠市场的成长。新兴市场的扩张、联合治疗的开发、适应症的扩大以及对精准医疗的日益关注,预计将在预测期内为全球苯丁酸钠市场提供成长机会。全球尿素循环障碍和癌症盛行率的上升推动了对有效治疗方法的需求,预计这将推动苯丁酸钠市场的成长。

然而,在预测期内,有限的认识和诊断不足、高昂的治疗成本、严格的监管要求以及副作用和安全问题将阻碍苯丁酸钠市场的成长。

本研究的主要特点

  • 对苯丁酸钠市场进行了详细分析,并预测了 2025 年至 2032 年期间的市场规模和年复合成长率(CAGR%),假设 2024 年为基准年。
  • 它还揭示了各个领域的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 该报告涵盖了苯丁酸钠市场的主要企业概况,基于公司亮点、产品系列、关键亮点、财务表现和策略等参数。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 苯丁酸钠市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 透过用于分析苯丁酸钠市场的各种策略矩阵,相关人员将更容易做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
  • 尿素循环障碍(UCD)盛行率不断上升
    • 限制因素
  • 缺乏认识和诊断不足
    • 机会
  • 拓展新兴市场
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 苯基丁酸钠市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 苯丁酸钠市场(依应用)2020-2032

  • 製药
  • 食品/饮料
  • 其他的

6. 苯丁酸钠市场(依通路划分),2020 年至 2032 年

  • 直销
  • 经销商销售
  • 网路零售

7. 苯丁酸钠市场(依最终用户划分),2020 年至 2032 年

  • 医院和诊所
  • 研究机构
  • 食品和饮料业
  • 化妆品产业
  • 其他行业

8. 2020-2032 年苯丁酸钠市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 中东和非洲
      • 海湾合作委员会国家
      • 以色列
      • 南非
      • 北非
      • 中部非洲
      • 其他中东地区

第九章 竞争态势

  • Horizon Therapeutics plc
  • Ammonett Pharma LLC
  • Medison Pharma Ltd.
  • Synageva BioPharma Corp.
  • Swedish Orphan Biovitrum AB(Sobi)
  • Entera Health, Inc.
  • Dipharma Francis SrI
  • Uncyclyd Pharma, Inc.

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6052

Sodium Phenylbutyrate Market is estimated to be valued at USD 2.19 Bn in 2025 and is expected to reach USD 3.45 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.19 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.70% 2032 Value Projection: USD 3.45 Bn

Sodium phenylbutyrate (SPB) is a notable pharmaceutical compound that has garnered significant attention in medical research and treatment approaches. As a derivative of phenylbutyric acid, SPB exhibits a wide array of therapeutic properties, making it a promising candidate for various medical conditions. Its primary application lies in the management of urea cycle disorders, a group of genetic conditions that impair the body's ability to eliminate ammonia effectively. Additionally, ongoing studies are exploring its potential for mitigating neurodegenerative diseases and cancer. This introduction aims to shed light on the essential role of sodium phenylbutyrate in advancing medical science and enhancing patient care.

Market Dynamics:

The increasing prevalence of urea cycle disorders (UCDs), growing awareness and diagnosis of rare diseases, and the expansion of orphan drug development are anticipated to drive growth of the global sodium phenylbutyrate market over the forecast period. Moreover, advancements in pharmaceutical research and development are also expected to boost the growth of the global sodium phenylbutyrate market over the forecast period. Expansion into emerging markets, development of combination therapies, expansion of indications, and increasing focus on precision medicine are expected to create growth opportunities for the global sodium phenylbutyrate market during the forecast period. The increasing prevalence of urea cycle disorders and cancer globally is driving the demand for effective treatments, which in turn is expected to boost the market growth for sodium phenylbutyrate.

However, limited awareness and underdiagnosis, high treatment costs, stringent regulatory requirements and side effects and safety concerns are expected to hamper growth of the sodium phenylbutyrate market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the sodium phenylbutyrate market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the sodium phenylbutyrate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Horizon Therapeutics plc, Ammonett Pharma LLC, Medison Pharma Ltd., Modern Dietetics Inc., Synageva BioPharma Corp., Medison Pharma Ltd., Swedish Orphan Biovitrum AB (Sobi), Entera Health, Inc., Dipharma Francis S.r.l., Ucyclyd Pharma, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The sodium phenylbutyrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the sodium phenylbutyrate market

Sodium Phenylbutyrate Market Detailed Segmentation:

  • By Application:
    • Pharmaceutical
    • Food & Beverages
    • Others
  • By Distribution Channel:
    • Direct Sales
    • Distributor Sales
    • Online Retail
  • By End User:
    • Hospitals and Clinics
    • Research Institutes
    • Food & Beverage Industry
    • Cosmetics Industry
    • Other Industries
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profile:
    • Horizon Therapeutics plc
    • Ammonett Pharma LLC
    • Medison Pharma Ltd.
    • Synageva BioPharma Corp.
    • Swedish Orphan Biovitrum AB (Sobi)
    • Entera Health, Inc.
    • Dipharma Francis S.r.l.
    • Ucyclyd Pharma, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Sodium Phenylbutyrate , By Application
    • Market Sodium Phenylbutyrate , By Distribution Channel
    • Market Sodium Phenylbutyrate , By End User
    • Market Sodium Phenylbutyrate , By region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of urea cycle disorders (UCDs)
    • Restraints
  • Limited awareness and underdiagnosis
    • Opportunities
  • Expansion into emerging markets
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Sodium Phenylbutyrate Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Sodium Phenylbutyrate Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Food & Beverages
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Sodium Phenylbutyrate Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Direct Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Distributor Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Online Retail
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Sodium Phenylbutyrate Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Food & Beverage Industry
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cosmetic Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Other Industries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Sodium Phenylbutyrate Market , By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • South Africa
      • North Africa
      • Central Africa
      • Rest of Middle East

9. Competitive Landscape

  • Horizon Therapeutics plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ammonett Pharma LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Medison Pharma Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Synageva BioPharma Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Swedish Orphan Biovitrum AB (Sobi)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Entera Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dipharma Francis S.r.I.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Uncyclyd Pharma, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us